The profile of gene expression and role of nuclear factor kappa B on glomerular injury in rats with Thy-1 nephritis

Clinical and Experimental Immunology

Volumn 152, Issue 3, 2008, Pages 559-567

  Wang, H ^a   Jiang, X M ^a   Xu, J H ^a   Xu, J ^a   Tong, J X ^a   Wang, Y W ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Extracelluar matrix; Glomerular mesangial cells; Mesangioproliferative glomerulonephritis; Nuclear factor kappa B; Thy 1 nephritis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HISTOPATHOLOGY; KIDNEY PARENCHYMA; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; RAT; RAT STRAIN; THY 1 NEPHRITIS; UPREGULATION;

EID: 43349105501     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03654.x     Document Type: Article

References (50)

1. 1 Yamamoto T, Wilson CB. Complement dependence of antibody‐induced mesangial cell injury in the rat. J Immunol 1987 ; 138: 3758–65.
2. 2 Couser WG, Pippin JW, Shankland SJ. Complement (C5b‐9) induces DNA synthesis in rat mesangial cells in vitro. Kidney Int 2001 ; 59: 905–12.
3. 3 Abe K, Li K, Sacks SH, Sheerin NS. The membrane attack complex, C5b‐9, up‐regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol 2004 ; 136: 60–6.
4. 4 Wang Y, He Q, Qin H et al. The complement C5b‐9 complexes induced injury of glomerular mesangial cells in rats with Thy‐1 nephritis by increasing nitric oxide synthesis. Life Sci 2006 ; 79: 182–92.
5. 5 Lu XC, Williams AJ, Yao C et al. Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res 2004 ; 77: 843–57.
6. 6 Preston GA, Waga I, Alcorta DA et al. Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney Int 2004 ; 65: 420–30.
7. 7 Schwab K, Witte DP, Aronow BJ, Devarajan P, Potter SS, Patterson LT. Microarray analysis of focal segmental glomerulosclerosis. Am J Nephrol 2004 ; 24: 438–47.
8. 8 Izumi Y, Izumiya Y, Shiota M et al. Gene expression profile in experimental mesangial proliferative glomerulonephritis. J Pharmacol Sci 2004 ; 96: 91–4.
9. 9 Ghosh S, Karin M. Missing pieces in the NF‐kappaB puzzle. Cell 2002 ; 109: S81–S96.
10. 10 Gomez‐Guerrero C, Lopez‐Franco O, Suzuki Y et al. Nitric oxide production in renal cells by immune complexes: role of kinases and nuclear factor‐kappaB. Kidney Int 2002 ; 62: 2022–34.
11. 11 Tsukinoki T, Sugiyama H, Sunami R et al. Mesangial cell Fas ligand: upregulation in human lupus nephritis and NFkappaB‐mediated expression in cultured human mesangial cells. Clin Exp Nephrol 2004 ; 8: 196–205.
12. 12 Sakai N, Wada T, Furuichi K et al. p38 MAPK phosphorylation and NF‐kappaB activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 2002 ; 17: 998–1004.
13. 13 Yano N, Endoh M, Fadden K et al. Comprehensive gene expression profile of the adult renal cortex: analysis by cDNA array hybridization. Kidney Int 2000 ; 57: 1452–9.
14. 14 Huo R, Zhu Y, Ma X, Lin M, Zhou Z, Sha J. Differential expression of glucose‐regulated protein 78 during spermatogenesis. Cell Tissue Res 2004 ; 316: 359–67.
15. 15 Brand K, Page S, Rogler G et al. Activated transcription factor nuclear factor‐kappa B is present in the atherosclerotic lesion. J Clin Invest 1996 ; 97: 1715–22.
16. 16 Nonaka M, Chen XH, Pierce JE et al. Prolonged activation of NF‐kappaB following traumatic brain injury in rats. J Neurotrauma 1999 ; 16: 1023–34.
17. 17 Hickenbottom SL, Grotta JC, Strong R, Denner LA, Aronowski J. Nuclear factor‐kappaB and cell death after experimental intracerebral hemorrhage in rats. Stroke 1999 ; 30: 2472–7.
18. 18 Nauta AJ, Daha MR, Tijsma O, Van de Water B, Tedesco F, Roos A. The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol 2002 ; 32: 783–91.
19. 19 Quigg RJ. Complement and autoimmune glomerular diseases. Curr Dir Autoimmun 2004 ; 7: 165–80.
20. 20 Turrnberg D, Cook HT. Complement and glomerulonephritis: new insights. Curr Opin Nephrol Hypertens 2005 ; 14: 223–8.
21. 21 Amere A, Coppo R. Role of apoptosis in pathogenesis and progression of renal diseases. Nephron 2000 ; 86: 99–104.
22. 22 Shimizu A, Kitamura H, Masada Y et al. Complement‐mediated killing of mesangial cells in experimental glomerulonephritis, cell death by a combination of apoptosis and necrosis. Nephron 2000 ; 86: 152–60.
23. 23 Sakai N, Iseki K, Suzuki S et al. Uninephrectomy induces progressive glomerulosclerosis and apoptosis in anti‐Thy1 glomerulonephritis. Pathol Int 2005 ; 55: 19–26.
24. 24 Wu SH, Wu XH, Lu C, Dong L, Zhou GP, Chen ZQ. Lipoxin A4 inhibits connective tissue growth factor‐induced production of chemokines in rat mesangial cells. Kidney Int 2006 ; 69: 248–56.
25. 25 Krishnaswami S, Ly QP, Rothman VL, Tuszynski GP. Thrombospondin‐1 promotes proliferative healing through stabilization of PDGF. J Sur Res 2002 ; 107: 124–30.
26. 26 Trachtman H. Nitric oxide and glomerulonephritis. Semin Nephrol 2004 ; 24: 324–32.
27. 27 Dinarello CA. Interleukin‐1 and interleukin‐1 antagonism. Blood 1991 ; 77: 1627–52.
28. 28 Gupta S, Clarkson MR, Duggan J, Brady HR. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 1996 ; 49: 1120–6.
29. 29 Ranieri E, Gesualdo L, Petrarulo F, Schena FP. Urinary IL‐6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int 2001 ; 50: 1990–2001.
30. 30 Neale TJ, Ojha PP, Exner M et al. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 1994 ; 94: 1577–84.
31. 31 Kilgore KS, Schmid E, Shanley TP et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin‐8 and monocyte chemoattractant protein‐1 through nuclear factor‐κB activation. Am J Pathol 1997 ; 150: 2019–31.
32. 32 Long J, Song N, Liu XP, Guo KJ, Guo RX. Nuclear factor‐kappaB activation on the reactive oxygen species in acute necrotizing pancreatitic rats. World J Gastroenterol 2005 ; 11: 4277–80.
33. 33 Kim MJ, Ryu GR, Kang JH et al. Inhibitory effects of epicatechin on interleukin‐1beta‐induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down‐regulation of NF‐kappaB activation. Biochem Pharmacol 2004 ; 68: 1775–85.
34. 34 Yoshioka K, Takemura T, Murakami K et al. In situ expression of cytokines in IgA nephritis. Kidney Int 1993 ; 44: 825–33.
35. 35 Collins T, Read MA, Neish AS. Transcriptional regulation of endothelial cells adhesion molecules: NF‐κB and cytokine‐inducible enhancers. FEBS Lett 1995 ; 9: 899–909.
36. 36 Baldwin ASJ. The NFκB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996 ; 14: 649–81.
37. 37 Barnes PJ, Karin M. Nuclear factor‐κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997 ; 336: 1066–71.
38. 38 Lopez‐Franco O, Suzuki Y, Sanjuan G et al. Nuclear factor‐κB inhibitors as potential novel anti‐inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol 2002 ; 161: 1497–505.
39. 39 Jansen A, Cook T, Taylor GM et al. Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 1994 ; 45: 1215–19.
40. 40 Cook HT, Ebrahim H, Jansen AS, Foster GR, Largen P, Cattell V. Expression of the gene for inducible nitric oxide synthase in experimental glomerulonephritis in the rat. Clin Exp Immunol 1994 ; 97: 315–20.
41. 41 Cook HT, Sullivan R. Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. Am J Pathol 1991 ; 139: 1047–52.
42. 42 Mosley K, Waddington SN, Ebrahim H, Cook T, Cattell V. Inducible nitric oxide synthase induction in Thy 1 glomerulonephritis is complement and reactive oxygen species dependent. Exp Nephrol 1999 ; 7: 26–34.
43. 43 Goto S, Yamamoto T, Feng L et al. Expression and localisation of inducible nitric oxide synthase in anti‐thy‐1 glomerulonephritis. Am J Pathol 1995 ; 147: 1133–41.
44. 44 Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992 ; 175: 1181–94.
45. 45 Nurmi A, Vartiainen N, Pihlaja R, Goldsteins G, Yrjänheikki J, Koistinaho J. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa‐B in neurons and protects against brain ischaemia with a wide therapeutic time window. J Neurochem 2004 ; 91: 755–65.
46. 46 Parodi FE, Mao D, Ennis TL, Bartoli MA, Thompson RW. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor‐kappaB. J Vasc Surg 2005 ; 41: 479–89.
47. 47 Gao LJ, Qiu W, Wang YW, Xu WH, Xu J, Tong JX. Sublytic complement C5b‐9 complexes induce thrombospondin‐1 production in rat glomerular mesangial cells via PI3‐k/Akt: association with activation of latent transforming growth factor‐β1. Clin Exp Immunol 2006 ; 144: 326–34.
48. 48 Tesch GH, Lan HY, Atkins RC et al. Role of interleukin‐1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am J Pathol 1997 ; 151: 141–50.
49. 49 Eitner F, Westerhuis R, Burg M et al. Role of interleukin‐6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int 1997 ; 51: 69–78.
50. 50 Floege J, Eng E, Yo ung BA, Johnson RJ. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl 1993 ; 39: S47–54.